Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.44 |
| ▸ | PPARG | P37231 | 7/20 | 0.44 |
| ▸ | PPARD | Q03181 | 7/20 | 0.44 |
| ▸ | PPARA | Q07869 | 7/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9587972 | 1.00 | CES2 (0.46) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL10844127 | 1.00 | CES2 (0.46) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL11672966 | 1.00 | CES2 (0.46) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL9498240 | 1.00 | CES2 (0.46) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL12814573 | 1.00 | CES2 (0.46) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL10994386 | 1.00 | CES2 (0.46) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL2294833 | 0.97 | — | — | |
| SCHEMBL256001 | 0.89 | — | — | |
| Acetic Acid SCHEMBL4879809 | 0.89 | GPR84 (0.52) | CES2CES1TSHRALDH1A1HSD17B10 | |
| Acetic Acid SCHEMBL19260206 | 0.86 | AKR1B1 (0.50) | CES2CES1TSHRALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4136067-B1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR AND COMPANY LTD (IN) | 2026-04-15 | — | — | EP | disclosed |
| US-12522780-B2 | Odorants and compositions comprising odorants | S H KELKAR AND COMPANY LIMITED (IN) | 2026-01-13 | — | — | US | disclosed |
| US-20230141482-A1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR & COMPANY LIMITED (IN) | 2023-05-11 | — | — | US | disclosed |
| EP-4136067-A1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H Kelkar and Company Limited (IN) | 2023-02-22 | — | — | EP | disclosed |
| CN-115551829-A | Odorants and compositions comprising odorants | 丝趣科尔卡有限公司 | 2022-12-30 | — | — | CN | disclosed |
| WO-2021209944-A1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR AND COMPANY LIMITED (IN) | 2021-10-21 | — | — | WO | disclosed |
| US-20080064624-A1 | Organoleptic Compounds and Their Use in Perfume Compositions | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2008-03-13 | — | — | US | disclosed |
| US-20080064624-A1 | Organoleptic Compounds and Their Use in Perfume Compositions | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2008-03-13 | — | — | US | disclosed |
| US-20080064624-A1 | Organoleptic Compounds and Their Use in Perfume Compositions | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2008-03-13 | — | — | US | disclosed |
| US-4052486-A | PROCESS FOR PREPARING CYCLIC PHOSPHINIC ACID ESTERS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064624-A1 | Organoleptic Compounds and Their Use in Perfume Compositions | CPT1A, CYP2E1, TRPA1 | CES2 21/4885CES1 87/4885TSHR 3410/4885 |
| US-20230141482-A1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | CDY1; CDY1B, ACMSD, ADH5 | CES2 770/4885CES1 1084/4885TSHR 4551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.